Who should enter clinical trials in oncology? 1986

E Perlin

UI MeSH Term Description Entries
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004992 Ethics, Medical The principles of professional conduct concerning the rights and duties of the physician, relations with patients and fellow practitioners, as well as actions of the physician in patient care and interpersonal relations with patient families. Medical Ethics
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

E Perlin
January 1946, Journal of the American Dental Association (1939),
E Perlin
July 2005, The Journal of reproductive medicine,
E Perlin
September 1998, Nature medicine,
E Perlin
January 1993, Clinical oncology (Royal College of Radiologists (Great Britain)),
E Perlin
January 2012, Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti,
E Perlin
April 2008, Bulletin de la Societe de pathologie exotique (1990),
E Perlin
August 2015, Nature reviews. Drug discovery,
Copied contents to your clipboard!